Cite
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
MLA
Newsome, P. N., et al. “A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.” New England Journal of Medicine, vol. 385, no. 12, Mar. 2021, pp. 1113–24. EBSCOhost, https://doi.org/10.1056/NEJMoa2028395.
APA
Newsome, P. N., Buchholtz, K., Cusi, K., Linder, M., Okanoue, T., Ratziu, V., Sanyal, A. J., Sejling, A.-S., Harrison, S. A., Newsome, P. N., Buchholtz, K., Cusi, K., Linder, M., Okanoue, T., Ratziu, V., Sanyal, A. J., Sejling, A.-S., Harrison, S. A., & NN9931-4296 Investigators. (2021). A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. New England Journal of Medicine, 385(12), 1113–1124. https://doi.org/10.1056/NEJMoa2028395
Chicago
Newsome, P. N., K. Buchholtz, K. Cusi, M. Linder, T. Okanoue, V. Ratziu, A. J. Sanyal, et al. 2021. “A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.” New England Journal of Medicine 385 (12): 1113–24. doi:10.1056/NEJMoa2028395.